Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Inflammatory Breast Cancer|Stage IIA Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer|Stage IIB Breast Cancer|Estrogen Receptor Negative|Progesterone Receptor Negative|HER2/Neu Negative
Interventions: DRUG: carboplatin|DRUG: paclitaxel albumin-stabilized nanoparticle formulation|OTHER: laboratory biomarker analysis
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)